Estrella Immunopharma, Inc.

Q1 2024 13F Holders

Symbol
ESLA
CUSIP
297584104
Type
Equity
Class
COM
Num filings
7
Total reported value, excl. options
$166 k
Manager Report Date Value ($000) Shares Option Type